Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 1

Interventions

Blood Specimen Collection 53Surveys and Questionnaires 49Specimen Handling 29Observation 15Radiotherapy 14Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 11Interviews as Topic 11Data Collection 11Drug Therapy 9darolutamide 8Biopsy 8palbociclib 7Watchful Waiting 7Tomography, X-Ray Computed 7Standard of Care 7ribociclib 6Magnetic Resonance Imaging 6Bevacizumab 6trastuzumab deruxtecan 5Ultrasonography 5Restraint, Physical 5Radiofrequency Ablation 5Patient Reported Outcome Measures 5Mental Status and Dementia Tests 5Mastectomy, Segmental 5Mass Screening 5Genetic Testing 5Breath Tests 5enzalutamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Quality of Life × 90 days × Clear all
NCT07226466 2026-05-22

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer

University of California, San Francisco

Not yet recruiting
40 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡